Andreas Rinne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Andreas Rinne has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Lutz Pott
Institute of Physiology, Ruhr-University Bochum, D-44780 Bochum, Germany
8 shared publications - Moritz Bünemann
University of Marburg: Philipps-Universitat Marburg
7 shared publications Kirsten Bender
Ruhr-Universitaet
6 shared publications- Lothar A. Blatter
Dept. of Physiology & Biophysics, Rush University Medical Center, 1750 W. Harrison St., Chicago, IL 60612, USA
4 shared publications Christoph Littwitz
Ruhr-Universitaet
3 shared publications- Florentina Pluteanu
Department of Anatomy, Animal Physiology and Biophysics, Faculty of Biology, University of Bucharest, 050095 Bucharest, Romania
3 shared publications
Latest Publications
- Open Access
- 28 August 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (9) , 1244
Ca2+ Signaling in Striated Muscle Cells During Intracellular Acidosis
The cytosolic pH (pHi) of mammalian cells is tightly maintained at values ~7.2. Cytoplasmic acidosis (pHi < 6.8) occurs when the intracellular proton concentration ([H+]i) exceeds the buffering capacity of the cytosol and transport processes to extrude protons are exhausted. During intracellular acidosis, the contractility of cardiac and skeletal muscle cells is strongly reduced, often at sufficient Ca2+ levels. A contraction of striated muscle is achieved when the intracellular calcium (Ca2+) concentration rises above resting levels. The amplitude and kinetics of Ca2+ signals are controlled by Ca2+ handling proteins and force is generated if Ca2+ ions interact with contractile filaments of the sarcomere. Some aspects of this phenomenon, such as the biochemical origin of excessive protons in working muscle cells and molecular interactions of protons with Ca2+ handling proteins or contractile filaments, are not yet fully understood. This review summarizes our current understanding of how striated muscle cells handle Ca2+ and H+ and how a rise in [H+]i may interfere with Ca2+ signaling in the working skeletal muscle (fatigue) or during ischemic events in cardiac muscle. Finally, we briefly address experimental strategies to measure Ca2+ signaling at different pH values with fluorescent probes and highlight their limitations.
- 28 August 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (9) , 1244
Open AccessCa2+ Signaling in Striated Muscle Cells During Intracellular Acidosis
The cytosolic pH (pHi) of mammalian cells is tightly maintained at values ~7.2. Cytoplasmic acidosis (pHi < 6.8) occurs when the intracellular proton concentration ([H+]i) exceeds the buffering capacity of the cytosol and transport processes to extrude protons are exhausted. During intracellular acidosis, the contractility of cardiac and skeletal muscle cells is strongly reduced, often at sufficient Ca2+ levels. A contraction of striated muscle is achieved when the intracellular calcium (Ca2+) concentration rises above resting levels. The amplitude and kinetics of Ca2+ signals are controlled by Ca2+ handling proteins and force is generated if Ca2+ ions interact with contractile filaments of the sarcomere. Some aspects of this phenomenon, such as the biochemical origin of excessive protons in working muscle cells and molecular interactions of protons with Ca2+ handling proteins or contractile filaments, are not yet fully understood. This review summarizes our current understanding of how striated muscle cells handle Ca2+ and H+ and how a rise in [H+]i may interfere with Ca2+ signaling in the working skeletal muscle (fatigue) or during ischemic events in cardiac muscle. Finally, we briefly address experimental strategies to measure Ca2+ signaling at different pH values with fluorescent probes and highlight their limitations.
- Open Access
- 23 December 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (12) , 1652
Charge Movements and Conformational Changes: Biophysical Properties and Physiology of Voltage-Dependent GPCRs
G protein-coupled receptors (GPCRs) regulate multiple cellular functions and represent important drug targets. More than 20 years ago, it was noted that GPCR activation (agonist binding) and signaling (G protein activation) are dependent on the membrane potential (VM). While it is now proven that many GPCRs display an intrinsic voltage dependence, the molecular mechanisms of how GPCRs sense depolarization of the plasma membrane are less well defined. This review summarizes the current knowledge of voltage-dependent signaling in GPCRs. We describe how voltage dependence was discovered in muscarinic receptors, present an overview of GPCRs that are regulated by voltage, and show how biophysical properties of GPCRs led to the discovery of voltage-sensing mechanisms in those receptors. Furthermore, we summarize physiological functions that have been shown to be regulated by voltage-dependent GPCR signaling of endogenous receptors in excitable tissues, such as the nervous system or the heart. Finally, we discuss challenges that remain in analyzing voltage-dependent signaling of GPCRs in vivo and present an outlook on experimental applications of the interesting concept of GPCR signaling.
- 23 December 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (12) , 1652
Open AccessCharge Movements and Conformational Changes: Biophysical Properties and Physiology of Voltage-Dependent GPCRs
G protein-coupled receptors (GPCRs) regulate multiple cellular functions and represent important drug targets. More than 20 years ago, it was noted that GPCR activation (agonist binding) and signaling (G protein activation) are dependent on the membrane potential (VM). While it is now proven that many GPCRs display an intrinsic voltage dependence, the molecular mechanisms of how GPCRs sense depolarization of the plasma membrane are less well defined. This review summarizes the current knowledge of voltage-dependent signaling in GPCRs. We describe how voltage dependence was discovered in muscarinic receptors, present an overview of GPCRs that are regulated by voltage, and show how biophysical properties of GPCRs led to the discovery of voltage-sensing mechanisms in those receptors. Furthermore, we summarize physiological functions that have been shown to be regulated by voltage-dependent GPCR signaling of endogenous receptors in excitable tissues, such as the nervous system or the heart. Finally, we discuss challenges that remain in analyzing voltage-dependent signaling of GPCRs in vivo and present an outlook on experimental applications of the interesting concept of GPCR signaling.
- Open Access
- 27 October 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (11) , 1365
Ca2+ Signaling in Cardiovascular Fibroblasts
Fibrogenesis is a physiological process required for wound healing and tissue repair. It is induced by activation of quiescent fibroblasts, which first proliferate and then change their phenotype into migratory, contractile myofibroblasts. Myofibroblasts secrete extracellular matrix proteins, such as collagen, to form a scar. Once the healing process is terminated, most myofibroblasts undergo apoptosis. However, in some tissues, such as the heart, myofibroblasts remain active and sensitive to neurohumoral factors and inflammatory mediators, which lead eventually to excessive organ fibrosis. Many cellular processes involved in fibroblast activation, including cell proliferation, protein secretion and cell contraction, are highly regulated by intracellular Ca2+ signals. This review summarizes current research on Ca2+ signaling pathways underlying fibroblast activation. We present receptor- and ion channel-mediated Ca2+ signaling pathways, discuss how localized Ca2+ signals of the cell nucleus may be involved in fibroblast activation and present Ca2+-sensitive transcription pathways relevant for fibroblast biology. When investigated, we highlight how the function of Ca2+-handling proteins changes during cardiac and pulmonary fibrosis. Many aspects of Ca2+ signaling remain unexplored in different types of cardiovascular fibroblasts in relation to pathologies, and a better understanding of Ca2+ signaling in fibroblasts will help to design targeted therapies against fibrosis.
- 27 October 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (11) , 1365
Open AccessCa2+ Signaling in Cardiovascular Fibroblasts
Fibrogenesis is a physiological process required for wound healing and tissue repair. It is induced by activation of quiescent fibroblasts, which first proliferate and then change their phenotype into migratory, contractile myofibroblasts. Myofibroblasts secrete extracellular matrix proteins, such as collagen, to form a scar. Once the healing process is terminated, most myofibroblasts undergo apoptosis. However, in some tissues, such as the heart, myofibroblasts remain active and sensitive to neurohumoral factors and inflammatory mediators, which lead eventually to excessive organ fibrosis. Many cellular processes involved in fibroblast activation, including cell proliferation, protein secretion and cell contraction, are highly regulated by intracellular Ca2+ signals. This review summarizes current research on Ca2+ signaling pathways underlying fibroblast activation. We present receptor- and ion channel-mediated Ca2+ signaling pathways, discuss how localized Ca2+ signals of the cell nucleus may be involved in fibroblast activation and present Ca2+-sensitive transcription pathways relevant for fibroblast biology. When investigated, we highlight how the function of Ca2+-handling proteins changes during cardiac and pulmonary fibrosis. Many aspects of Ca2+ signaling remain unexplored in different types of cardiovascular fibroblasts in relation to pathologies, and a better understanding of Ca2+ signaling in fibroblasts will help to design targeted therapies against fibrosis.
- 1 December 2019
- Published by Elsevier in Cellular Signalling
- Vol. 64, 109418
Receptor-specific regulation of atrial GIRK channel activity by different Ca2+-dependent PKC isoforms
- 1 December 2019
- Published by Elsevier in Cellular Signalling
- Vol. 64, 109418
Receptor-specific regulation of atrial GIRK channel activity by different Ca2+-dependent PKC isoforms
- 1 January 2018
- Published by Elsevier in Cellular Signalling
- Vol. 42, 114-126
The allosteric site regulates the voltage sensitivity of muscarinic receptors
- 1 January 2018
- Published by Elsevier in Cellular Signalling
- Vol. 42, 114-126
The allosteric site regulates the voltage sensitivity of muscarinic receptors
- 1 February 2017
- Published by Elsevier in Biophysical Journal
- Vol. 112 (3) , 170a-171a
The Allosteric Site is Required for Voltage Dependence of Muscarinic GPCRs
- 1 February 2017
- Published by Elsevier in Biophysical Journal
- Vol. 112 (3) , 170a-171a
The Allosteric Site is Required for Voltage Dependence of Muscarinic GPCRs
- Open Access
- 1 December 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (51) , 26410-26426
Receptor Species-dependent Desensitization Controls KCNQ1/KCNE1 K+ Channels as Downstream Effectors of Gq Protein-coupled Receptors
- 1 December 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (51) , 26410-26426
Open AccessReceptor Species-dependent Desensitization Controls KCNQ1/KCNE1 K+ Channels as Downstream Effectors of Gq Protein-coupled Receptors
- Open Access
- 1 February 2016
- Published by Elsevier in Biophysical Journal
- Vol. 110 (3) , 425a
Receptor Species-Dependent Signaling of Gqpcrs Controls IKs Activity
- 1 February 2016
- Published by Elsevier in Biophysical Journal
- Vol. 110 (3) , 425a
Open AccessReceptor Species-Dependent Signaling of Gqpcrs Controls IKs Activity
- 3 November 2015
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 8 (401) , ra110
The mode of agonist binding to a G protein–coupled receptor switches the effect that voltage changes have on signaling
Signaling by many heterotrimeric guanine nucleotide–binding protein (G protein)–coupled receptors (GPCRs) is either enhanced or attenuated by changes in plasma membrane potential. To identify structural correlates of the voltage sensitivity of GPCR signaling, we chose muscarinic acetylcholine receptors (the M1, M3, and M5 isoforms) as a model system. We combined molecular docking analysis with Förster resonance energy transfer (FRET)–based assays that monitored receptor activity under voltage clamp conditions. When human embryonic kidney (HEK) 293 cells expressing the individual receptors were stimulated with the agonist carbachol, membrane depolarization enhanced signaling by the M1 receptor but attenuated signaling by the M3 and M5 receptors. Furthermore, whether membrane depolarization enhanced or inhibited receptor signaling depended on the type of agonist. Membrane depolarization attenuated M3 receptor signaling when the receptor was bound to carbachol or acetylcholine, whereas depolarization enhanced signaling when the receptor was bound to either choline or pilocarpine. Docking calculations predicted that there were two distinct binding modes for these ligands, which were associated with the effect of depolarization on receptor function. From these calculations, we identified a residue in the M3 receptor that, when mutated, would alter the binding mode of carbachol to resemble that of pilocarpine in silico. Introduction of this mutated M3 receptor into cells confirmed that the membrane depolarization enhanced, rather than attenuated, signaling by the carbachol-bound receptor. Together, these data suggest that the directionality of the voltage sensitivity of GPCR signaling is defined by the specific binding mode of each ligand to the receptor.
- 3 November 2015
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 8 (401) , ra110
The mode of agonist binding to a G protein–coupled receptor switches the effect that voltage changes have on signaling
Signaling by many heterotrimeric guanine nucleotide–binding protein (G protein)–coupled receptors (GPCRs) is either enhanced or attenuated by changes in plasma membrane potential. To identify structural correlates of the voltage sensitivity of GPCR signaling, we chose muscarinic acetylcholine receptors (the M1, M3, and M5 isoforms) as a model system. We combined molecular docking analysis with Förster resonance energy transfer (FRET)–based assays that monitored receptor activity under voltage clamp conditions. When human embryonic kidney (HEK) 293 cells expressing the individual receptors were stimulated with the agonist carbachol, membrane depolarization enhanced signaling by the M1 receptor but attenuated signaling by the M3 and M5 receptors. Furthermore, whether membrane depolarization enhanced or inhibited receptor signaling depended on the type of agonist. Membrane depolarization attenuated M3 receptor signaling when the receptor was bound to carbachol or acetylcholine, whereas depolarization enhanced signaling when the receptor was bound to either choline or pilocarpine. Docking calculations predicted that there were two distinct binding modes for these ligands, which were associated with the effect of depolarization on receptor function. From these calculations, we identified a residue in the M3 receptor that, when mutated, would alter the binding mode of carbachol to resemble that of pilocarpine in silico. Introduction of this mutated M3 receptor into cells confirmed that the membrane depolarization enhanced, rather than attenuated, signaling by the carbachol-bound receptor. Together, these data suggest that the directionality of the voltage sensitivity of GPCR signaling is defined by the specific binding mode of each ligand to the receptor.
- Open Access
- 1 November 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (45) , 27311-27320
Membrane Potential Controls the Efficacy of Catecholamine-induced β1-Adrenoceptor Activity
- 1 November 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (45) , 27311-27320
Open AccessMembrane Potential Controls the Efficacy of Catecholamine-induced β1-Adrenoceptor Activity